fda marty makary - Search News

Order byBest matchMost fresh

Covid-19, FDA

Digest more

FDA’s Makary: Covid shot guidance coming soon

the agency will soon provide clear guidelines to vaccine manufacturers for annually updating their Covid-19 shots.

· 5d

· 19h · on MSN

New FDA chiefs limit Covid-19 shots to elderly, sick

· 1d · on MSN

FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know

FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups

The U.S. Food and Drug Administration (FDA) has decided that only seniors and people at high risk should get the latest COVID-19 booster shots this fall.

· 21h

· 1d

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

New COVID booster rules could limit shots for people under 65

The changes will likely limit access to the shots to seniors and individuals with pre-existing conditions who are at higher risk of serious infections.

Axios · 1d

· 1d

US to limit Covid boosters to over-65s or those at high risk

WBAL · 17h

FDA plans to limit COVID shots to those over 65 or with high-risk conditions

STAT1d

FDA will limit Covid vaccines to people over 65 or at high risk of serious illness, leaders say

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of serious illness

11h

FDA Commissioner Makary Cites Real Clear Journal Article At Panel On Talc In The American Food Supply

"Expert Panels with the FDA" are a series of roundtable discussions to provide an open public discourse on the latest medical and scientific information on several important topics. At this roundtable,

Fierce Pharma1d

FDA lays out stricter COVID vaccine policy in pivot from 'one-size-fits-all' approach

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for certain approvals. | FDA Commissioner Marty Makary, M.D., and CBER head Vinay Prasad, M.D.

BioSpace3d

Makary’s ‘Conditional Approval’ Pathway for Rare Diseases Poses More Questions Than Answers

While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner Marty Makary’s proposal is light on details and raises potential concerns about safety,

1don MSN

Psychedelic stocks rise as FDA chief’s comments seen favorable to industry

Companies focused on psychedelic medicines traded higher for the second straight session on Tuesday after FDA Commissioner Marty Makary said evaluating the potential of psilocybin, MDMA, and other psychedelics will be a “top priority” under the Trump administration.

East Idaho News on MSN1d

FDA to limit future Covid-19 shots to older people and those at risk of serious infection

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit future vaccines to older Americans and people at higher risk of serious Covid-19 infection.

BioSpace1d

Makary Backs Psychedelics for Neuropsych, Promises Speedy Review

In an interview on Friday, FDA Commissioner Marty Makary threw his weight behind psychedelic therapies, noting that patients taking these substances experience significant benefits for various neuropsychiatric conditions.